Total Payments
$516,185
2024 Payments
$90,478
Companies
36
Transactions
1,891
Medicare Patients
661
Medicare Billing
$97,375
Payment Breakdown by Category
Other$416,763 (80.7%)
Travel$59,216 (11.5%)
Food & Beverage$29,216 (5.7%)
Consulting$10,703 (2.1%)
Education$287.52 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $416,763 | 227 | 80.7% |
| Travel and Lodging | $59,216 | 215 | 11.5% |
| Food and Beverage | $29,216 | 1,434 | 5.7% |
| Consulting Fee | $10,703 | 6 | 2.1% |
| Education | $287.52 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $151,933 | 343 | $0 (2024) |
| ABBVIE INC. | $111,922 | 236 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $86,943 | 448 | $0 (2022) |
| Allergan, Inc. | $41,202 | 139 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $31,682 | 91 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $31,289 | 38 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25,703 | 76 | $0 (2023) |
| ITI, Inc. | $8,696 | 45 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $7,924 | 30 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $7,866 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90,478 | 260 | Vanda Pharmaceuticals Inc. ($31,144) |
| 2023 | $111,122 | 291 | AbbVie Inc. ($75,462) |
| 2022 | $35,705 | 187 | Otsuka America Pharmaceutical, Inc. ($29,591) |
| 2021 | $27,423 | 202 | Janssen Pharmaceuticals, Inc ($7,303) |
| 2020 | $17,652 | 139 | Allergan, Inc. ($10,141) |
| 2019 | $47,955 | 214 | Otsuka America Pharmaceutical, Inc. ($18,649) |
| 2018 | $77,883 | 275 | Sunovion Pharmaceuticals Inc. ($28,786) |
| 2017 | $107,968 | 323 | Sunovion Pharmaceuticals Inc. ($48,588) |
All Payment Transactions
1,891 individual payment records from CMS Open Payments — Page 1 of 76
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $27.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $26.33 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $9.53 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Insomnia | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.89 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $783.13 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,724.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 138 | 387 | $47,420 | $23,668 |
| 2022 | 4 | 146 | 449 | $52,868 | $25,921 |
| 2021 | 6 | 179 | 422 | $48,595 | $24,643 |
| 2020 | 3 | 198 | 478 | $49,469 | $23,143 |
Total Patients
661
Total Services
1,736
Medicare Billing
$97,375
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 217 | $23,002 | $11,714 | 50.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 132 | $16,368 | $7,632 | 46.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 20 | 22 | $5,202 | $2,921 | 56.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 16 | 16 | $2,848 | $1,400 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 262 | $27,772 | $14,239 | 51.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 155 | $19,220 | $8,336 | 43.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 14 | 15 | $2,850 | $2,052 | 72.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 17 | 17 | $3,026 | $1,294 | 42.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 268 | $28,408 | $15,234 | 53.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 94 | $11,656 | $4,974 | 42.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 16 | $2,512 | $1,507 | 60.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 12 | 12 | $2,280 | $1,343 | 58.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 12 | 13 | $2,314 | $1,078 | 46.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 19 | $1,425 | $506.30 | 35.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 101 | 237 | $25,122 | $10,644 | 42.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 128 | $15,872 | $7,003 | 44.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 71 | 113 | $8,475 | $5,496 | 64.9% |
About Dr. Wendy Weinstein, MD
Dr. Wendy Weinstein, MD is a Psychiatry healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679523484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wendy Weinstein, MD has received a total of $516,185 in payments from pharmaceutical and medical device companies, with $90,478 received in 2024. These payments were reported across 1,891 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($416,763).
As a Medicare-enrolled provider, Weinstein has provided services to 661 Medicare beneficiaries, totaling 1,736 services with total Medicare billing of $97,375. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Buffalo, NY
- Active Since 05/11/2006
- Last Updated 01/30/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679523484
Products in Payments
- VRAYLAR (Drug) $152,889
- REXULTI (Drug) $152,620
- LATUDA (Drug) $86,930
- Trintellix (Drug) $56,358
- FANAPT (Drug) $31,160
- CAPLYTA (Drug) $9,058
- QUVIVIQ (Drug) $7,924
- SPRAVATO (Drug) $7,850
- ARISTADA (Drug) $1,205
- INGREZZA (Drug) $1,163
- COBENFY (Drug) $928.42
- TRINTELLIX (Drug) $694.98
- BRINTELLIX (Drug) $467.75
- AUSTEDO (Drug) $380.46
- Austedo XR (Drug) $312.74
- HETLIOZ (Drug) $268.82
- Dayvigo (Drug) $244.86
- Azstarys (Drug) $231.38
- VIIBRYD (Drug) $230.55
- LYBALVI (Drug) $217.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Buffalo
Qasim Jaffri, D.o, D.O
Psychiatry — Payments: $10,515
Psychiatry $10,515
Dr. Subhdeep Virk, Md, MD
Psychiatry — Payments: $8,458
Psychiatry $8,458
Dr. Jarod Masci, M.d, M.D
Psychiatry — Payments: $7,362
Psychiatry $7,362
John Napoli, Phd, PHD
Psychiatry — Payments: $7,335
Psychiatry $7,335
Dr. Irina Schwartz, M.d, M.D
Psychiatry — Payments: $4,649
Psychiatry $4,649
Dr. Jeffery Grace, M.d, M.D
Psychiatry — Payments: $2,277
Psychiatry $2,277